| Name | Title | Contact Details |
|---|
CMC's Department of Pediatrics and the hospital's administration are committed to quality care for children, said Steve Carlson, CMC's president and chief executive officer.
New Mexico Cancer Care is a Santa Fe, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
MedOne unlocks the most appropriate prescription at the most affordable price for organizations and their health plan members nationwide. The MedOne model delivers real prescription savings by cutting out the traditional "PBM" middlemen and facilitating direct relationships between health plans and high-performing pharmacies. Once we establish a transparent and aligned marketplace, we partner with organizations to optimize "where" and "what" members fill to reduce pharmacy costs and improve health outcomes. Ready for a new approach to pharmacy benefits? We invite you to experience the difference!